common.study.topics.clinical

Maternal Hyperoxygenation in Congenital Heart Disease

common.study.values.description

“Maternal Hyperoxygenation in Congenital Heart Disease”

A pilot study investigating the safety and feasibility of chronic maternal hyperoxygenation in the setting of fetal congenital heart disease

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Drug - Maternal Hyperoxygenation

Oxygen via nasal prongs at 4L/min continuously during 2nd and 3rd trimester of pregnancy until birth

participant.views.study.view.additional

participant.views.study.view.scientific-title

Maternal Hyperoxygenation in Congenital Heart Disease

common.study.values.clinical-trial-id

NCT03136835

participant.views.study.view.id

QdJk2e